Seth van Voorhees

Seth Van Voorhees is a seasoned financial executive with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as Chief Financial Officer at United Theranostics since September 2024, Seth is instrumental in advancing innovative radiopharmaceutical therapies for precision cancer care. Prior to this role, Seth held the position of Chief Financial Officer and Treasurer at NRx Pharmaceuticals, where efforts focused on developing treatments for bipolar depression. Additional leadership roles include Chief Financial Officer for PDS Biotechnology, Research Frontiers Inc., and American Pacific Corporation, as well as serving as Principal at Case Advisors LLC. Seth holds an MBA in Finance from Columbia Business School and a Ph.D. in Chemistry from the University of Pennsylvania, complemented by a Bachelor's degree in Chemistry from Stony Brook University.